-
1
-
-
79551672781
-
-
rfaut Joint United Nations Joint United Nations Programme on HIV/AIDS. Accessed May 2011. Available from
-
Joint United Nations Programme on HIV/AIDS: Report on the Global AIDS Epidemic. Joint United Nations Programme on HIV/AIDS 2010. Accessed May 2011. Available from http://www.unaids.org/en/media/unaids/contentassets/documents/ unaidspublication/2010/20101123-globalreport- en.pdf.
-
(2010)
Programme on HIV/AIDS: Report on the Global AIDS Epidemic.
-
-
-
2
-
-
33748125153
-
Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapy
-
DOI 10.1097/01.qai.0000230521.86964.86, PII 0012633420060900000007
-
Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, and Sungkanuparph S: Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006;43:42-46. (Pubitemid 44306486)
-
(2006)
Journal of Acquired Immune Deficiency Syndromes
, vol.43
, Issue.1
, pp. 42-46
-
-
Manosuthi, W.1
Chottanapand, S.2
Thongyen, S.3
Chaovavanich, A.4
Sungkanuparph, S.5
-
3
-
-
33846898997
-
Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy
-
DOI 10.1086/510489
-
Puthanakit T, Aurpibul L, Oberdorfer P, et al.: Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. Clin Infect Dis 2007;44:599-604. (Pubitemid 46233267)
-
(2007)
Clinical Infectious Diseases
, vol.44
, Issue.4
, pp. 599-604
-
-
Puthanakit, T.1
Aurpibul, L.2
Oberdorfer, P.3
Akarathum, N.4
Kanjananit, S.5
Wannarit, P.6
Sirisanthana, T.7
Sirisanthana, V.8
-
4
-
-
43949087566
-
+ cell evolution among children and adolescents infected with HIV: 5 Years and counting
-
DOI 10.1086/587900
-
Patel K, Hernán MA, Williams PL, et al.: Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis 2008;46:1751-1760. (Pubitemid 351706777)
-
(2008)
Clinical Infectious Diseases
, vol.46
, Issue.11
, pp. 1751-1760
-
-
Patel, K.1
Hernan, M.A.2
Williams, P.L.3
Seeger, J.D.4
McIntosh, K.5
Van Dyke, R.B.6
Seage III, G.R.7
-
5
-
-
80053220672
-
HIV-1-resistance-associated mutations after failure of firstline antiretroviral treatment among children in resourcepoor regions: A systematic review
-
Sigaloff KC, Calis JC, Geelen SP, van Vugt M, and De Wit TF: HIV-1-resistance-associated mutations after failure of firstline antiretroviral treatment among children in resourcepoor regions: A systematic review. Lancet Infect Dis 2011; 11:769-779.
-
(2011)
Lancet Infect Dis
, vol.11
, pp. 769-779
-
-
Sigaloff, K.C.1
Calis, J.C.2
Geelen, S.P.3
Van Vugt, M.4
De Wit, T.F.5
-
6
-
-
29444451897
-
Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'Ivoire
-
DOI 10.1097/01.inf.0000190413.88671.92
-
Chaix ML, Rouet F, Kouakoussui KA, et al.: Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan,Cô te d'Ivoire. Pediatr Infect Dis J 2005;24:1072-1076. (Pubitemid 43011063)
-
(2005)
Pediatric Infectious Disease Journal
, vol.24
, Issue.12
, pp. 1072-1076
-
-
Chaix, M.-L.1
Rouet, F.2
Kouakoussui, K.A.3
Laguide, R.4
Fassinou, P.5
Montcho, C.6
Blanche, S.7
Rouzioux, C.8
Msellati, P.9
-
7
-
-
33750433935
-
Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy
-
DOI 10.1097/01.inf.0000243211.36690.d5, PII 0000645420061100000012
-
Averbuch D, Schapiro JM, Lanier ER, et al.: Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy. Pediatr Infect Dis J 2006;25:1049-1056. (Pubitemid 44657816)
-
(2006)
Pediatric Infectious Disease Journal
, vol.25
, Issue.11
, pp. 1049-1056
-
-
Averbuch, D.1
Schapiro, J.M.2
Lanier, E.R.3
Gradstein, S.4
Gottesman, G.5
Kedem, E.6
Einhorn, M.7
Grisaru-Soen, G.8
Ofir, M.9
Engelhard, D.10
Grossman, Z.11
-
8
-
-
34249907870
-
Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure
-
DOI 10.1002/jmv.20912
-
Lwembe R, Ochieng W, Panikulam A, et al.: Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure. J Med Virol 2007;79:865-872. (Pubitemid 46871541)
-
(2007)
Journal of Medical Virology
, vol.79
, Issue.7
, pp. 865-872
-
-
Lwembe, R.1
Ochieng, W.2
Panikulam, A.3
Mongoina, C.O.4
Palakudy, T.5
Koizumi, Y.6
Kageyama, S.7
Yamamoto, N.8
Shioda, T.9
Musoke, R.10
Owens, M.11
Songok, E.M.12
Okoth, F.A.13
Ichimura, H.14
-
9
-
-
48749107884
-
Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan
-
Adjé-Touré C, Hanson DL, Talla-Nzussouo N, et al.: Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Cô te d'Ivoire. AIDS Res Hum Retroviruses 2008;24:911-917.
-
(2008)
Cô te d'Ivoire. AIDS Res Hum Retroviruses
, vol.24
, pp. 911-917
-
-
Adjé-Touré, C.1
Hanson, D.L.2
Talla-Nzussouo, N.3
-
10
-
-
62749141273
-
High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations
-
Gody JC, Charpentier C, Mbitikon O, et al.: High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations. J Acquir Immune Defic Syndr 2008;49:566-569.
-
(2008)
J Acquir Immune Defic Syndr
, vol.49
, pp. 566-569
-
-
Gody, J.C.1
Charpentier, C.2
Mbitikon, O.3
-
11
-
-
74049104390
-
Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure
-
Vaz P, Chaix ML, Jani I, et al.: Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure. Pediatr Infect Dis J 2009;28:e283-287.
-
(2009)
Pediatr Infect Dis J
, vol.28
-
-
Vaz, P.1
Chaix, M.L.2
Jani, I.3
-
12
-
-
77950353556
-
Level of viral load and antiretroviral resistance after 6 months of nonnucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali
-
Germanaud D, Derache A, Traore M, et al.: Level of viral load and antiretroviral resistance after 6 months of nonnucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali. J Antimicrob Chemother 2010;65:118-124.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 118-124
-
-
Germanaud, D.1
Derache, A.2
Traore, M.3
-
13
-
-
78650714700
-
Early failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children
-
Ruel TD, Kamya MR, Li P, et al.: Early failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr 2011;56:44-50.
-
(2011)
J Acquir Immune Defic Syndr
, vol.56
, pp. 44-50
-
-
Ruel, T.D.1
Kamya, M.R.2
Li, P.3
-
14
-
-
84855594339
-
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: A crosssectional evaluation in HIV type 1-infected children living in Central African Republic
-
Charpentier C, Gody JC, Mbitikon O, et al.: Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: A crosssectional evaluation in HIV type 1-infected children living in Central African Republic. AIDS Res Hum Retroviruses 2012;28:87-94.
-
(2012)
AIDS Res Hum Retroviruses
, vol.28
, pp. 87-94
-
-
Charpentier, C.1
Gody, J.C.2
Mbitikon, O.3
-
15
-
-
49949108207
-
The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa
-
Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke De Wit TF, and Schuurman R: The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Antivir Ther 2008;13:625-639.
-
(2008)
Antivir Ther
, vol.13
, pp. 625-639
-
-
Hamers, R.L.1
Derdelinckx, I.2
Van Vugt, M.3
Stevens, W.4
Rinke De Wit, T.F.5
Schuurman, R.6
-
16
-
-
0041627405
-
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy
-
Vergne L, Kane CT, Laurent C, et al.: Low rate of genotypic HIV-1 drug-resistant strains in Senegalese government initiative of access to antiretroviral therapy. AIDS 2003;17: S31-38. (Pubitemid 36951667)
-
(2003)
AIDS
, vol.17
, Issue.SUPPL. 3
-
-
Vergne, L.1
Kane, C.T.2
Laurent, C.3
Diakhate, N.4
Ngom Gueye, N.F.5
Gueye, P.M.6
Sow, P.S.7
Faye, M.A.8
Liegeois, F.9
Ndir, A.10
Laniece, I.11
Peeters, M.12
Ndoye, I.13
Mboup, S.14
Delaporte, E.15
-
17
-
-
47649104656
-
Antiretroviral therapy for HIV infection in infants and children: Toward universal access
-
World Health Organization. Geneva. World Health Organization. Accessed January 2010. Available from
-
World Health Organization: Antiretroviral therapy for HIV infection in infants and children: Toward universal access. Recommendations for a public health approach. Geneva. World Health Organization 2007. Accessed January 2010. Available from http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf.
-
(2007)
Recommendations for a public health approach
-
-
-
18
-
-
34250673163
-
Multicenter evaluation of the new Abbott Realtime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA
-
DOI 10.1128/JCM.02385-06
-
Schutten M, Peters D, Back NK, et al.: Multicenter evaluation of the new Abbott RealTime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 2007;45:1712-1717. (Pubitemid 46933896)
-
(2007)
Journal of Clinical Microbiology
, vol.45
, Issue.6
, pp. 1712-1717
-
-
Schutten, M.1
Peters, D.2
Back, N.K.T.3
Beld, M.4
Beuselinck, K.5
Foulongne, V.6
Geretti, A.-M.7
Pandiani, L.8
Tiemann, C.9
Niesters, H.G.M.10
-
19
-
-
0035003858
-
HIV-1 subtyping using phylogenetic analysis of pol gene sequences
-
DOI 10.1016/S0166-0934(01)00272-5, PII S0166093401002725
-
Pasquier C, Millot N, and Njouom R: HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 2001;94:45-54. (Pubitemid 32411477)
-
(2001)
Journal of Virological Methods
, vol.94
, Issue.1-2
, pp. 45-54
-
-
Pasquier, C.1
Millot, N.2
Njouom, R.3
Sandres, K.4
Cazabat, M.5
Puel, J.6
Izopet, J.7
-
20
-
-
27544496497
-
An automated genotyping system for analysis of HIV-1 and other microbial sequences
-
DOI 10.1093/bioinformatics/bti607
-
De Oliveira T, Deforche K, Cassol S, et al.: An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005;21:3797-3800. (Pubitemid 41535530)
-
(2005)
Bioinformatics
, vol.21
, Issue.19
, pp. 3797-3800
-
-
De Oliveira, T.1
Deforche, K.2
Cassol, S.3
Salminen, M.4
Paraskevis, D.5
Seebregts, C.6
Snoeck, J.7
Van Rensburg, E.J.8
Wensing, A.M.J.9
Van De Vijver, D.A.10
Boucher, C.A.11
Camacho, R.12
Vandamme, A.-M.13
-
21
-
-
47649104656
-
Antiretroviral therapy for HIV infection in infants and children: Towards universal access
-
World Health Organization. World Health Organization. Accessed July 2011. Available from
-
World Health Organization: Antiretroviral therapy for HIV infection in infants and children: Towards universal access. Recommendations for a public health approach. World Health Organization 2010. Accessed July 2011. Available from http://whqlibdoc.who.int/publications/2010/9789241599801-eng.pdf.
-
(2010)
Recommendations for a public health approach
-
-
-
22
-
-
34748846895
-
Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy
-
DOI 10.1097/QAI.0b013e31814278c0, PII 0012633420071001000009
-
Kamya MR, Mayanja-Kizza H, Kambugu A, et al.: Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr 2007;46:187-193. (Pubitemid 47482614)
-
(2007)
Journal of Acquired Immune Deficiency Syndromes
, vol.46
, Issue.2
, pp. 187-193
-
-
Kamya, M.R.1
Mayanja-Kizza, H.2
Kambugu, A.3
Bakeera-Kitaka, S.4
Semitala, F.5
Mwebaze-Songa, P.6
Castelnuovo, B.7
Schaefer, P.8
Spacek, L.A.9
Gasasira, A.F.10
Katabira, E.11
Colebunders, R.12
Quinn, T.C.13
Ronald, A.14
Thomas, D.L.15
Kekitiinwa, A.16
-
23
-
-
34147098059
-
Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from Kwazulu-Natal, South Africa
-
Reddi A, Leeper SC, Grobler AC, et al.: Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from Kwazulu-Natal, South Africa. BMC Pediatr 2007;17:7-13.
-
(2007)
BMC Pediatr
, vol.17
, pp. 7-13
-
-
Reddi, A.1
Leeper, S.C.2
Grobler, A.C.3
-
24
-
-
70249136191
-
Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
-
Jittamala P, Puthanakit T, Chaiinseeard S, and Sirisanthana V: Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Pediatr Infect Dis J 2009;28:826-830.
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 826-830
-
-
Jittamala, P.1
Puthanakit, T.2
Chaiinseeard, S.3
Sirisanthana, V.4
-
25
-
-
36048946593
-
Effectiveness of highly active antiretroviral therapy in HIV-positive children: Evaluation at 12 months in a routine program in Cambodia
-
DOI 10.1542/peds.2006-3503
-
Janssens B, Raleigh B, Soeung S, et al.: Effectiveness of highly active antiretroviral therapy in HIV-positive children: Evaluation at 12 months in a routine program in Cambodia. Pediatrics 2007;120:e1134-1140. (Pubitemid 350085507)
-
(2007)
Pediatrics
, vol.120
, Issue.5
-
-
Janssens, B.1
Raleigh, B.2
Soeung, S.3
Akaob, K.4
Te, V.5
Gupta, J.6
Vun, M.C.7
Ford, N.8
Nouhinf, J.9
Nerrienet, E.10
-
26
-
-
0036488217
-
Efficacy of highly active antiretroviral therapy in HIV-1 infected children
-
DOI 10.1016/S1473-3099(02)00183-4
-
van Rossum AM, Fraaij PL, and De Groot R: Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis 2002;2:93-102. (Pubitemid 36114143)
-
(2002)
Lancet Infectious Diseases
, vol.2
, Issue.2
, pp. 93-102
-
-
Van Rossum, A.M.C.1
Fraaij, P.L.A.2
De Groot, R.3
-
27
-
-
74049138608
-
Emergence of drug resistance in HIV-1 subtype C infected children failing the South African national antiretroviral roll-out program
-
Wallis CL, Erasmus L, Varughese S, Ndiweni D, and Stevens WS: Emergence of drug resistance in HIV-1 subtype C infected children failing the South African national antiretroviral roll-out program. Pediatr Infect Dis J 2009;28: 1123-1125.
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 1123-1125
-
-
Wallis, C.L.1
Erasmus, L.2
Varughese, S.3
Ndiweni, D.4
Stevens, W.S.5
-
28
-
-
77952556299
-
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda
-
Towler WI, Barlow-Mosha L, Church JD, et al.: Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses 2010;26:563-568.
-
(2010)
AIDS Res Hum Retroviruses
, vol.26
, pp. 563-568
-
-
Towler, W.I.1
Barlow-Mosha, L.2
Church, J.D.3
-
29
-
-
33847369795
-
La résistance du VIH-1 aux antirétroviraux chez les enfants infectés: du nouveau-né a l'adolescent
-
DOI 10.1016/j.arcped.2006.12.007, PII S0929693X06006269
-
Delaugerre C, Chaix M L, Warszawki J, Rouzioux C, and Blanche S: HIV-1 drug resistance in French infectedchildren: From newborn to adolescent. Arch Pediatr 2007;14: 298-302. (Pubitemid 46349610)
-
(2007)
Archives De Pediatrie
, vol.14
, Issue.3
, pp. 298-302
-
-
Delaugerre, C.1
Chaix, M.-L.2
Warszawski, J.3
Rouzioux, C.4
Blanche, S.5
-
30
-
-
70249136191
-
Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy
-
Podjanee J, Thanyawee P, Sukrapee C, and Virat S: Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. Pediatr Infect Dis J 2009;28:826-830.
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 826-830
-
-
Podjanee, J.1
Thanyawee, P.2
Sukrapee, C.3
Virat, S.4
-
31
-
-
1542618485
-
Comparison of Drug Resistance Mutations and Their Interpretation in Patients Infected with Non-B HIV-1 Variants and Matched Patients Infected with HIV-1 Subtype B
-
DOI 10.1097/00126334-200404010-00001
-
Montes B, Vergne L, Peeters M, Reynes J, Delaporte E, and Segondy M: Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B. J Acquir Immune Defic Syndr 2004;35:329-336. (Pubitemid 38332792)
-
(2004)
Journal of Acquired Immune Deficiency Syndromes
, vol.35
, Issue.4
, pp. 329-336
-
-
Montes, B.1
Vergne, L.2
Peeters, M.3
Reynes, J.4
Delaporte, E.5
Segondy, M.6
-
32
-
-
0029024089
-
Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC)
-
Schuurman R, Nijhuis M, van Leeuwen R, et al.: Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). J Infect Dis 1995;171: 1411-1419.
-
(1995)
J Infect Dis
, vol.171
, pp. 1411-1419
-
-
Schuurman, R.1
Nijhuis, M.2
Van Leeuwen, R.3
-
33
-
-
12244282436
-
Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation
-
Zaccarelli M, Perno CF, Forbici F, et al.: Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation. Antivir Ther 2003;8:51-56. (Pubitemid 36368302)
-
(2003)
Antiviral Therapy
, vol.8
, Issue.1
, pp. 51-56
-
-
Zaccarelli, M.1
Perno, C.F.2
Forbici, F.3
Cingolani, A.4
Liuzzi, G.5
Bertoli, A.6
Trotta, M.P.7
Bellocchi, M.C.8
Di Giambenedetto, S.9
Tozzi, V.10
Gori, C.11
D'Arrigo, R.12
De Longis, P.13
Noto, P.14
Girardi, E.15
De Luca, A.16
Antinori, A.17
-
34
-
-
11844278253
-
Rationale for maintenance of the M184V resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients
-
Turner D, Brenner BG, Routy JP, Petrella M, and Wainberg MA: Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients. New Microbiol 2004;27:31-39. (Pubitemid 40090987)
-
(2004)
New Microbiologica
, vol.27
, Issue.2 SUPPL. 1
, pp. 31-39
-
-
Turner, D.1
Brenner, B.G.2
Routy, J.-P.3
Petrella, M.4
Wainberg, M.A.5
-
35
-
-
59649126954
-
In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine
-
Paredes R, Sagar M, Marconi VC, et al.: In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine. J Virol 2009;83:2038-2043.
-
(2009)
J Virol
, vol.83
, pp. 2038-2043
-
-
Paredes, R.1
Sagar, M.2
Marconi, V.C.3
-
36
-
-
0036523770
-
Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy
-
Ait-Khaled M, Rakik A, Griffin P, et al.: Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1 infected adults with no prior antiretroviral therapy. Antivir Ther 2002;7:43-51. (Pubitemid 36285551)
-
(2002)
Antiviral Therapy
, vol.7
, Issue.1
, pp. 43-51
-
-
Ait-Khaled, M.1
Rakik, A.2
Griffin, P.3
Cutrell, A.4
Fischl, M.A.5
Clumeck, N.6
Greenberg, S.B.7
Rubio, R.8
Peters, B.S.9
Pulido, F.10
Gould, J.11
Pearce, G.12
Spreen, W.13
Tisdale, M.14
Lafon, S.15
-
37
-
-
0037118912
-
M184V is associated with a iow incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine
-
DOI 10.1097/00002030-200208160-00017
-
Ait-Khaled M, Stone C, Amphlett G, et al.: M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine. AIDS 2002;16:1686-1689. (Pubitemid 34921117)
-
(2002)
AIDS
, vol.16
, Issue.12
, pp. 1686-1689
-
-
Ait-Khaled, M.1
Stone, C.2
Amphlett, G.3
Clotet, B.4
Staszewski, S.5
Katlama, C.6
Tisdale, M.7
-
38
-
-
0038369071
-
HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study
-
Ait-Khaled M, Rakik A, Griffin P, et al.: HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CAN 2007 study. Antivir Ther 2003;8: 111-120. (Pubitemid 36565891)
-
(2003)
Antiviral Therapy
, vol.8
, Issue.2
, pp. 111-120
-
-
Ait-Khaled, M.1
Rakik, A.2
Griffin, P.3
Stone, C.4
Richards, N.5
Thomas, D.6
Falloon, J.7
Tisdale, M.8
-
39
-
-
0036124432
-
The M184V mutation reduces the selective excision of zidovudine 5′-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1
-
DOI 10.1128/JVI.76.7.3248-3256.2002
-
Boyer PL, Sarafianos SG, Arnold E, and Hughes SH: The M184V mutation reduces the selective excision of zidovudine 5¢-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1. J Virol 2002;76:3248-3256. (Pubitemid 34224526)
-
(2002)
Journal of Virology
, vol.76
, Issue.7
, pp. 3248-3256
-
-
Boyer, P.L.1
Sarafianos, S.G.2
Arnold, E.3
Hughes, S.H.4
-
40
-
-
3042856914
-
Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients
-
Masquelier B, Tamalet C, Monte's B, et al.: Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitorexperienced patients. Antivir Ther 2004;9:315-323. (Pubitemid 38878747)
-
(2004)
Antiviral Therapy
, vol.9
, Issue.3
, pp. 315-323
-
-
Masquelier, B.1
Tamalet, C.2
Montes, B.3
Descamps, D.4
Peytavin, G.5
Bocket, L.6
Wirden, M.7
Izopet, J.8
Schneider, V.9
Ferre, V.10
Ruffault, A.11
Palmer, P.12
Trylesinski, A.13
Miller, M.14
Brun-Vezinet, F.15
Costagliola, D.16
-
41
-
-
0035037383
-
Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy
-
DOI 10.1128/JVI.75.11.4999-5008.2001
-
Bacheler L, Jeffrey S, Hanna G, et al.: Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol 2001;75:4999-5008. (Pubitemid 32448520)
-
(2001)
Journal of Virology
, vol.75
, Issue.11
, pp. 4999-5008
-
-
Bacheler, L.1
Jeffrey, S.2
Hanna, G.3
D'Aquila, R.4
Wallace, L.5
Logue, K.6
Cordova, B.7
Hertogs, K.8
Larder, B.9
Buckery, R.10
Baker, D.11
Gallagher, K.12
Scarnati, H.13
Tritch, R.14
Rizzo, C.15
-
42
-
-
0033994776
-
Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen
-
DOI 10.1097/00002030-200001280-00001
-
Casado JL, Hertogs K, Ruiz L, et al.: Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen. AIDS 2000;14:F1-7. (Pubitemid 30116454)
-
(2000)
AIDS
, vol.14
, Issue.2
-
-
Casado, J.L.1
Hertogs, K.2
Ruiz, L.3
Dronda, F.4
Van Cauwenberge, A.5
Arno, A.6
Garcia-Arata, I.7
Bloor, S.8
Bonjoch, A.9
Blazquez, J.10
Clotet, B.11
Larder, B.12
-
43
-
-
35548942272
-
Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: A meta-analysis
-
DOI 10.1093/ije/dym104
-
Arrivé E, Newell ML, Ekouevi DK, et al.: Prevalence of resistance to nevirapine in mothers and children after singledose exposure to prevent vertical transmission of HIV-1: A meta-analysis. Int J Epidemiol 2007;36:1009-1021. (Pubitemid 350018545)
-
(2007)
International Journal of Epidemiology
, vol.36
, Issue.5
, pp. 1009-1021
-
-
Arrive, E.1
Newell, M.-L.2
Ekouevi, D.K.3
Chaix, M.-L.4
Thiebaut, R.5
Masquelier, B.6
Leroy, V.7
Van De Perre, P.8
Rouzioux, C.9
Dabis, F.10
-
44
-
-
79955450369
-
Excellent adherence to antiretrovirals in HIV + Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
-
Haberer JE, Cook A, Walker AS, et al.: Excellent adherence to antiretrovirals in HIV + Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects. PLoS One 2011;6:e18505.
-
(2011)
PLoS One
, vol.6
-
-
Haberer, J.E.1
Cook, A.2
Walker, A.S.3
-
45
-
-
77950263958
-
Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa
-
vanZyl GU, CottonMF, ClaassenM, Abrahams C, and Preiser W: Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa. Pediatr Infect Dis J 2010;29:370-371.
-
(2010)
Pediatr Infect Dis J
, vol.29
, pp. 370-371
-
-
Van Zyl, G.U.1
Cotton, M.F.2
Claassen, M.3
Abrahams, C.4
Preiser, W.5
-
46
-
-
83455200006
-
Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic
-
Charpentier C, Gody JC, Tisserand P, et al.: Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic. Antiviral Ther 2011;16:1347-1350.
-
(2011)
Antiviral Ther
, vol.16
, pp. 1347-1350
-
-
Charpentier, C.1
Gody, J.C.2
Tisserand, P.3
-
47
-
-
79951715989
-
Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon
-
Charpentier C, Talla F, Nguepi E, Si-Mohamed A, and Be'lec L: Virological failure and HIV type 1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon. AIDS Res Hum Retroviruses 2011;27:221-230.
-
(2011)
AIDS Res Hum Retroviruses
, vol.27
, pp. 221-230
-
-
Charpentier, C.1
Talla, F.2
Nguepi, E.3
Si-Mohamed, A.4
Be'lec, L.5
-
48
-
-
77957135518
-
Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children
-
Buck WC, Kabue MM, Kazembe PN, and Kline MW: Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children. J Int AIDS Soc 2010;13:31.
-
(2010)
J Int AIDS Soc
, vol.13
, pp. 31
-
-
Buck, W.C.1
Kabue, M.M.2
Kazembe, P.N.3
Kline, M.W.4
-
49
-
-
62849127651
-
Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms
-
Cotte L, Trabaud MA, Tardy JC, et al.: Prediction of the virological response to etravirine in clinical practice: Comparison of three genotype algorithms. J Med Virol 2009; 81:672-677.
-
(2009)
J Med Virol
, vol.81
, pp. 672-677
-
-
Cotte, L.1
Trabaud, M.A.2
Tardy, J.C.3
-
50
-
-
70449601946
-
Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: The Swiss HIV Cohort Study (SHCS)
-
Scherrer AU, Hasse B, von Wyl V, et al.: Prevalence of etravirine mutations and impact on response to treatment in routine clinical care: The Swiss HIV Cohort Study (SHCS). HIV Med 2009;10:647-656.
-
(2009)
HIV Med
, vol.10
, pp. 647-656
-
-
Scherrer, A.U.1
Hasse, B.2
Von Wyl, V.3
-
51
-
-
75749098448
-
Resistanceassociated mutations to etravirine (TMC-125) in antiretroviral-nai?ve patients infected with non-B HIV-1 subtypes
-
Mai?ga AI, Descamps D, Morand-Joubert L, et al.: Resistanceassociated mutations to etravirine (TMC-125) in antiretroviral-nai?ve patients infected with non-B HIV-1 subtypes. Antimicrob Agents Chemother 2010;54:728-733.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 728-733
-
-
Maiga, A.I.1
Descamps, D.2
Morand-Joubert, L.3
|